A computational method for prioritizing targeted therapies in precision oncology: performance analysis in the SHIVA01 trial.

NPJ Precis Oncol · 2021 · PMC8222375 · PMID 34162980

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

did not reach statistical significanceno p-value reported

However, there was a trend of patients having worse OS in the low DDA tier; the difference did not reach statistical significance (8.78 months versus 12.09 months).

also in 111,027 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.